Stock Market News
Venture Life Group extends Alliance Pharma manufacturing contract to 2025
Venture Life Group announced on Wednesday that it has extended its manufacturing contract with Alliance Pharma until 2025 and secured business in excess of that currently undertaken for Alliance.
The AIM-traded self-care group said the deal will generate additional revenues to the company of at least 1.6m annually, with the addition of further product manufacturing expected to begin in the second half of 2018.
A statement said the deal placed Venture Life Group "at the forefront" of Alliance Pharma's strategic distributors.
Jerry Randall, chief executive of Venture Life, said: "In addition to the significant additional business Alliance has agreed to place with us, a further positive is that as part of this deal, we have also been given the opportunity to pitch for future new business that Alliance may put out to tender. We are now well positioned as a valued strategic partner to Alliance and our strong relationship will give shareholders confidence in us as we go forward."
Alliance Pharma is an international pharmaceutical company active in more than 100 countries through direct sales, joint ventures and distribution networks.
The company currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products.
Peter Butterfield, chief executive of Alliance Pharma plc, said: "We are actively fostering longer term relationships with our key strategic suppliers and are pleased to extend our relationship with Venture Life. Their consistent service and quality excellence will play a pivotal role in delivering growth and unlocking future benefits for both sides."
As of 1217 BST, Venture Life Group's shares were up 9.52% at 46.00p.
The AIM-traded self-care group said the deal will generate additional revenues to the company of at least 1.6m annually, with the addition of further product manufacturing expected to begin in the second half of 2018.
A statement said the deal placed Venture Life Group "at the forefront" of Alliance Pharma's strategic distributors.
Jerry Randall, chief executive of Venture Life, said: "In addition to the significant additional business Alliance has agreed to place with us, a further positive is that as part of this deal, we have also been given the opportunity to pitch for future new business that Alliance may put out to tender. We are now well positioned as a valued strategic partner to Alliance and our strong relationship will give shareholders confidence in us as we go forward."
Alliance Pharma is an international pharmaceutical company active in more than 100 countries through direct sales, joint ventures and distribution networks.
The company currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products.
Peter Butterfield, chief executive of Alliance Pharma plc, said: "We are actively fostering longer term relationships with our key strategic suppliers and are pleased to extend our relationship with Venture Life. Their consistent service and quality excellence will play a pivotal role in delivering growth and unlocking future benefits for both sides."
As of 1217 BST, Venture Life Group's shares were up 9.52% at 46.00p.
Related share prices |
---|
Venture Life Group (VLG) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price